Apoptosis: (2) Characteristics of apoptosis

Journal of the Formosan Medical Association

Volumn 98, Issue 8, 1999, Pages 531-542

  Wang, Tzu Hao ^a   Wang, Hsin Shih ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Apoptotic morphology; Biochemical detection of apoptosis; Caspase; Phagocytosis

Indexed keywords

APOPTOSIS; CELL INTERACTION; CELL PROLIFERATION; ENZYME ACTIVATION; GENE CONTROL; PHAGOCYTE; PROTEIN TARGETING; REVIEW;

APOPTOSIS; CASPASES; CELL MEMBRANE; ENZYME ACTIVATION; PHAGOCYTES;

EID: 0032883043     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (121)

1. Flemming W: Uber die Bildung von Richtungsfiguren in Saugethiereiern beim Untergang Graaf'scher Follikel. Arch Anat EntwGesch 1885:221-44.
2. Nissen F: Uber das Verhalten der Kerne in den Milchdrusenzellen bei der Absonderung. Arch Mikroskop Anat 1886;26:337-42.
3. Graper L: Eine neue Anschauung uber physiologische Zellausschaltung. Arch Zellforsch 1914;12:373-94.
4. Arends MJ, Wyllie AH: Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991;32:223-54.
5. Kerr JFR: Definition of apoptosis and overview of its incidence. In: Lavin M, Watters D, eds. Programmed Cell Death. Chur, Switzerland: Harwood Academic Publishers GmbH, 1993:1-13.
6. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-6.
7. Wyllie AH, Morris RG, Smith AL, et al: Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984;142:67-77.
8. Hockenbery D: Defining apoptosis. Am J Pathol 1995;146: 16-9.
9. Cohen GM, Sun XM, Snowden RT, et al: Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J 1992; 286:331-4.
10. Oberhammer FA, Pavelka M, Sharma S, et al: Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta-1. Proc Natl Acad Sci USA 1992;89:5408-12.
11. Tomei LD, Shapiro JP, Cope FO: Apoptosis in C3H/10T1/ 2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc Natl Acad Sci USA 1993;90:853-7.
12. Jacobson MD, Burne JF, Raff MC: Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 1994;13:1899-1910.
13. Wang TH, Wang HS: p53, Apoptosis and human cancers. J Formos Med Assoc 1996;95:509-22.
14. Casciola-Rosen L, Rosen A, Petri M, et al: Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 1996;93:1624-9.
15. Kerr JFR, Gobe GC, Winterford CM, et al: Chapter 1: Anatomical methods in cell death. Cell Death, Vol 46. San Diego: Academic Press, 1995:1-27.
16. Kidd VJ: Proteolytic activities that mediate apoptosis. Annu Rev Physiol 1998;60:533-73.
17. Sakahira H, Enari M, Nagata S: Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998;391:96-9.
18. Villa P, Kaufmann SH, Earnshaw WC: Caspases and caspase inhibitors. Trends Biochem Sci 1997;22:388-93.
19. Majno G, Joris I: Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995;146:3-15.
20. Liu ZG, Hsu H, Goeddel DV, et al: Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 1996;87:565-76.
21. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 1997;326:1-16.
22. Martin SJ, Reutelingsperger CP, McGahon AJ, et al: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995;182:1545-56.
23. Savill J: Recognition and phagocytosis of cells undergoing apoptosis. Br Med Bull 1997;53:491-508.
24. Savill J: Apoptosis. Phagocytic docking without shocking. Nature 1998;392:442-3.
25. Savill JS, Henson PM, Haslett C: Phagocytosis of aged human neutrophils by macrophages is mediated by a novel "charge-sensitive" recognition mechanism. J Clin Invest 1989;84:1518-27.
26. Frazier WA: Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells. J Cell Biol 1987; 105:625-32.
27. Savill J, Hogg N, Ren Y, Haslett C: Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 1992;90:1513-22.
28. Gahmberg CG, Tolvanen M: Why mammalian cell surface proteins are glycoproteins. Trends Biochem Sci 1996; 21:308-11.
29. Morris RG, Hargreaves AD, Duvall E, et al: Hormone-induced cell death. 2. Surface changes in thymocytes undergoing apoptosis. Am J Pathol 1984;115:426-36.
30. Duvall E, Wyllie AH, Morris RG: Macrophage recognition of cells undergoing programmed cell death (apoptosis). Immunology 1985;56:351-8.
31. Fadok VA, Voelker DR, Campbell PA, et al: Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992;148:2207-16.
32. Verhoven B, Schlegel RA, Williamson P: Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 1995;182: 1597-601.
33. Bratton DL, Fadok VA, Richter DA, et al: Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J Biol Chem 1997; 272:26159-65.
34. Zou H, Henzel WJ, Liu X, et al: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997;90:405-13.
35. Susin SA, Lorenzo HK, Zamzami N, et al: Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999;397:441-6.
36. Zamzami N, Susin SA, Marchetti P, et al: Mitochondrial control of nuclear apoptosis. J Exp Med 1996;183:1533-44.
37. Koopman G, Reutelingsperger CP, Kuijten GA, et al: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994;84:1415-20.
38. Wang TH, Popp DM, Wang HS, et al: Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells. J Biol Chem 1999:274:8208-16.
39. Lazebnik YA, Cole S, Cooke CA, et al: Nuclear events of apoptosis in vitro in cell-free mitotic extracts: a model system for analysis of the active phase of apoptosis. J Cell Biol 1993;123:7-22.
40. Lazebnik YA, Kaufmann SH, Desnoyers S, et al: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994;371:346-7.
41. Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci 1997;22:299-306.
42. Woo M, Hakem R, Soengas MS, et al: Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 1998;12:806-19.
43. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-6.
44. Wang S, Miura M, Jung YK, et al: Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 1998;92:501-9.
45. Humke EW, Ni J, Dixit VM: ERICE, a novel FLICE-activatable caspase. J Biol Chem 1998;273:15702-7.
46. Hu S, Snipas SJ, Vincenz C, et al: Caspase-14 is a novel developmentally regulated protease. J Biol Chem 1998; 273:29648-53.
47. Alnemri ES, Livingston DJ, Nicholson DW, et al: Human ICE/CED-3 protease nomenclature. Cell 1996;87:171.
48. Cheng EH, Kirsch DG, Clem RJ, et al: Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997; 278:1966-8.
49. Clem RJ, Cheng EH, Karp CL, et al: Modulation of cell death by Bcl-XL through caspase interaction. Proc Natl Acad Sci USA 1998;95:554-9.
50. Liu X, Zou H, Slaughter C, et al: DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997;89:175-84.
51. Kuida K, Zheng TS, Na S, et al: Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996;384:368-72.
52. Kumar A, Commane M, Flickinger TW, et al: Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 1997;278: 1630-2.
53. Li P, Nijhawan D, Budihardjo I, et al: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479-89.
54. Hakem R, Hakem A, Duncan GS, et al: Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998;94:339-52.
55. Kuida K, Haydar TF, Kuan CY, et al: Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998;94:325-37.
56. Chinnaiyan AM, O'Rourke K, Tewari M, et al: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995;81:505-12.
57. Levkau B, Koyama H, Raines EW, et al: Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell 1998;1:553-63.
58. Tan X, Wang JY. The caspase-RB connection in cell death. Trends Cell Biol 1998;8:116-20.
59. Kayalar C, Ord T, Testa MP, et al: Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition. Proc Natl Acad Sci USA 1996;93:2234-8.
60. Mashima T, Naito M, Fujita N, et al: Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem Biophys Res Commun 1995;217:1185-92.
61. Mashima T, Naito M, Noguchi K, et al: Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene 1997;14:1007-12.
62. Zhou BB, Li H, Yuan J, et al: Caspase-dependent activation of cyclin-dependent kinases during Fas-induced apoptosis in Jurkat cells. Proc Natl Acad Sci USA 1998;95: 6785-90.
63. Song Q, Lees-Miller SP, Kumar S, et al: DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. EMBO J 1996;15:3238-46.
64. Waterhouse N, Kumar S, Song Q, et al: Heteronuclear ribonucleoproteins C1 and C2, components of the spliceosome, are specific targets of interleukin1 beta-converting enzyme-like proteases in apoptosis. J Biol Chem 1996;271:29335-41.
65. Wen LP, Fahrni JA, Troie S, et al: Cleavage of focal adhesion kinase by caspases during apoptosis. J Biol Chem 1997;272:26056-61.
66. Cryns VL, Bergeron L, Zhu H, et al: Specific cleavage of alpha-fodrin during Fas-and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1beta-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease. J Biol Chem 1996;271:31277-82.
67. Martin SJ, O'Brien GA, Nishioka WK, et al: Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem 1995;270:6425-8.
68. Vanags DM, Porn-Ares MI, Coppola S, et al: Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem 1996;271:31075-85.
69. Kothakota S, Azuma T, Reinhard C, et al: Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 1997;278:294-8.
70. Greidinger EL, Miller DK, Yamin TT, et al: Sequential activation of three distinct ICE-like activities in Fas-ligated Jurkat cells. FEBS Lett 1996;390:299-303.
71. Lazebnik YA, Takahashi A, Moir RD, et al: Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci USA 1995;92:9042-6.
72. Ucker DS, Meyers J, Obermiller PS: Activation-driven T cell death. II. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death. J Immunol 1992;149:1583-92.
73. Chen L, Marechal V, Moreau J, et al: Proteolytic cleavage of the mdm2 oncoprotein during apoptosis. J Biol Chem 1997;272:22966-73.
74. Gu Y, Sarnecki C, Aldape RA, et al: Cleavage of poly(ADP-ribose) polymerase by interleukin-1 beta converting enzyme and its homologs TX and Nedd-2. J Biol Chem 1995; 270:18715-8.
75. Jeggo PA: DNA repair: PARP - another guardian angel? Curr Biol 1998;8:R49-51.
76. Kaufmann SH, Desnoyers S, Ottaviano Y, et al: Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993;53:3976-85.
77. Fattman CL, An B, Dou QP: Characterization of interior cleavage of retinoblastoma protein in apoptosis. J Cell Biochem 1997;67:399-408.
78. Janicke RU, Walker PA, Lin XY, et al: Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J 1996;15:6969-78.
79. Tan X, Martin SJ, Green DR, et al: Degradation of retinoblastoma protein in tumor necrosis factor-and CD95-induced cell death. J Biol Chem 1997;272:9613-6.
80. Na S, Chuang TH, Cunningham A, et al: D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis. J Biol Chem 1996;271:11209-13.
81. Cardone MH, Salvesen GS, Widmann C, et al: The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 1997;90:315-23.
82. Rudel T, Bokoch GM: Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 1997;276:1571-4.
83. Emoto Y, Manome Y, Meinhardt G, et al: Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. EMBO J 1995;14:6148-56.
84. Datta R, Kojima H, Yoshida K, et al: Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J Biol Chem 1997;272:20317-20.
85. Beyaert R, Kidd VJ, Cornelis S, et al: Cleavage of PITSLRE kinases by ICE/CASP-1 and CPP32/CASP-3 during apoptosis induced by tumor necrosis factor. J Biol Chem 1997;272:11694-7.
86. Wissing D, Mouritzen H, Egeblad M, et al: Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc Natl Acad Sci USA 1997;94:5073-7.
87. Wang X, Pai JT, Wiedenfeld EA, et al: Purification of an interleukin-1 beta converting enzyme-related cysteine protease that cleaves sterol regulatory element-binding proteins between the leucine zipper and transmembrane domains. J Biol Chem 1995;270:18044-50.
88. Wang X, Zelenski NG, Yang J, et al: Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J 1996;15:1012-20.
89. Compton MM: A biochemical hallmark of apoptosis: internucleosomal degradation of the genome. Cancer Metastasis Rev 1992;11:105-119.
90. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119: 493-501.
91. Wijsman JH, Jonker RR, Keijzer R, et al: A new method to detect apoptosis in paraffin section: in situ end-labeling of fragmented DNA. J Histochem Cytochem 1993; 41:7-21.
92. Barry MA, Eastman A. Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. Arch Biochem Biophys 1993;300:440-50.
93. Montague JW, Hughes FM, Jr., Cidlowski JA. Native recombinant cyclophilins A, B, and C degrade DNA independently of peptidylprolyl cis-trans-isomerase activity. Potential roles of cyclophilins in apoptosis. J Biol Chem 1997;272:6677-84.
94. Peitsch MC, Polzar B, Stephan H, et al: Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J 1993;12:371-7.
95. Enari M, Sakahira H, Yokoyama H, et al: A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998;391:43-50.
96. Ucker DS, Obermiller PS, Eckhart W, et al: Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes. Mol Cell Biol 1992;12:3060-9.
97. Bortner CD, Nicklas BE, Cidlowski O, et al: The role of DNA fragmentation in apoptosis. Trends Cell Biol 1995; 5:21-26.
98. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
99. Raff MC: Social controls on cell survival and cell death. Nature 1992;356:397-400.
100. Hetts SW: To die or not to die: an overview of apoptosis and its role in diseases. JAMA 1998;279:300-7.
101. Voll RE, Herrmann M, Roth EA, et al: Immunosuppressive effects of apoptotic cells. Nature 1997;390: 350-1.
102. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al: Lethal effect of the anti-Fas antibody in mice. Nature 1993;364:806-9.
103. Alberts B, Bray D, Lewis J, et al: eds. Molecular Biology of the Cell. 3rd ed. New York: Garland Publishing, 1994.
104. Wu YC, Horvitz HR: The C. elegans cell corpse engulfment gene ced-7 encodes a protein similar to ABC transporters. Cell 1998;93:951-60.
105. Luciani MF, Chimini G: The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. EMBO J 1996;15:226-35.
106. Flora PK, Gregory CD: Recognition of apoptotic cells by human macrophages: inhibition by a monocyte/macrophage-specific monoclonal antibody. Eur J Immunol 1994;24:2625-32.
107. Devitt A, Moffatt OD, Raykundalia C, et al: Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998;392:505-9.
108. Platt N, Suzuki H, Kurihara Y, et al: Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. Pror Natl Acad Sci USA 1996;93:12456-60.
109. Hall SE, Savill JS, Henson PM, et al: Apoptotic neutrophils are phagocytosed by fibroblasts with participation of the fibroblast vitronectin receptor and involvement of a mannose/fucose-specific lectin. J Immunol 1994;153:3218-27.
110. Dini L, Lentini A, Diez GD, et al: Phagocytosis of apoptotic bodies by liver endothelial cells. J Cell Sci 1995;108:967-73.
111. Dini L, Autuori F, Lentini A, et al: The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor. FERS Lett 1992;296:174-8.
112. Fadok VA, Savill JS, Haslett C, et al: Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992; 149:4029-35.
113. Pradhan D, Krahling S, Williamson P, et al: Multiple systems for recognition of apoptotic lymphocytes by macrophages. Mol Biol Cell 1997;8:767-78.
114. Savill J, Dransfield I, Hogg N, et al: Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 1990;343:170-3.
115. Greenwalt DE, Lipsky RH, Ockenhouse CF, et al: Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992;80:1105-15.
116. Endemann G, Stanton LW, Madden KS, et al: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993;268:11811-6.
117. Ren Y, Silverstein RL, Allen J, et al: CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 1995;181:1857-62.
118. Navazo MD, Daviet L, Savill J, et al: Identification of a domain (155-183) on CD36 implicated in the phagocytosis of apoptotic neutrophils. J Biol Chem 1996;271:15381-5.
119. Ellis RE, Yuan JY, Horvitz HR: Mechanisms and functions of cell death. Annu Rev Cell Biol 1991;7:663-98.
120. Wu YC, Horvitz HR: C. elegans phagocytosis and cell-migration protein CED-5 is similar to human DOCK180. Nature 1998;392:501-4.
121. Hasegawa H, Kiyokawa E, Tanaka S, et al: DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane. Mol Cell Biol 1996;16:1770-6.